Federal Circuit Affirms: Hospira Dexmedetomidine Patents Are Invalid

Mealey's (January 9, 2020, 3:24 PM EST) -- WASHINGTON, D.C. — A panel of the Federal Circuit U.S. Court of Appeals on Jan. 9 found no clear error in an Illinois federal judge’s holding that a single claim of...

To view the full article, register now.